Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at William Blair lowered their Q1 2024 earnings per share estimates for Viking Therapeutics in a research report issued to clients and investors on Wednesday, February 7th. William Blair analyst A. Hsieh now expects that the biotechnology company will post earnings per share of ($0.27) for […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at William Blair cut their Q1 2024 earnings per share estimates for Viking Therapeutics in a report released on Wednesday, February 7th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.27) per share for the quarter, down from […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares gapped up prior to trading on Thursday after StockNews.com upgraded the stock to a sell rating. The stock had previously closed at $24.48, but opened at $25.75. Viking Therapeutics shares last traded at $28.04, with a volume of 1,146,586 shares. A number of other brokerages also […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares reached a new 52-week high on Friday after Maxim Group raised their price target on the stock from $35.00 to $50.00. Maxim Group currently has a buy rating on the stock. Viking Therapeutics traded as high as $30.40 and last traded at $29.20, with a volume […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) Director Sarah Kathryn Rouan sold 25,000 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $28.05, for a total transaction of $701,250.00. The sale was disclosed in a filing with the Securities & Exchange Commission, […]